Overall, these finding provide the foundation for understanding the molecular regulatory mechanisms of FNDC5/irisin and may lay the groundwork for therapeutic targeting of these factors for treatment of metabolic disease. The gene discussed is FNDC5; the disease is Other metabolic disease.